/Companies

Neurotrope

Newark, US · Founded 2013 · Nevada corporation · 1 known investors

Find your way into Neurotrope

Sign up to see every warm intro you have to Neurotrope

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Neurotrope team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

RW
Robert WeinsteinExecutive
CS
Charles S. RamatExecutive

Board

LD
Larry D. Altstiel, MDBoard director
WS
William SingerVice Chairman of the Board
PE
Paul E. FreimanChairman of the Board
JM
Jay M. HaftBoard director
JG
James GottliebBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$39.8M disclosed across 2 rounds · 2015–2016

▶$24.5MraisedDec 2016 · 221 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua SilvermanDirector
  • Robert WeinsteinExecutive Officer
  • James GottliebDirector
  • Shana PharesDirector
  • Kenneth GorelickDirector
  • Dan AlkonExecutive Officer
  • William SingerDirector
  • Bruce BernsteinDirector
  • Susanne WilkeExecutive Officer, Director
Offering amount
$24.5M
Amount sold
$24.5M
Sales commissions
$2.5M
Placement agents
Katalyst Securities LLC, GP Nurmenkari Inc.
First sale
Nov 2016
Incorporated
Corporation, Nevada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.3MraisedNov 2015 · 136 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert WeinsteinExecutive Officer
  • Larry D. Altstiel, MDDirector
  • William SingerDirector
  • Charles S. RamatExecutive Officer, Director
  • Paul E. FreimanDirector
  • Jay M. HaftDirector
  • James GottliebDirector
Offering amount
$20M
Amount sold
$15.3M
Sales commissions
$1.5M
Placement agents
Katalyst Securities LLC
First sale
Nov 2015
Incorporated
Corporation, Nevada, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Neurotrope's investors?
Neurotrope's investors include NGN Capital.
How much funding has Neurotrope raised?
Neurotrope has disclosed $39.8M raised across 2 rounds.
Where is Neurotrope headquartered?
Neurotrope is headquartered in Newark, US.